Apollo Hospitals Enterprise LTD (Ahel) increases its strategy of medical tourism, which aims to diversify its overseas base of patients for Bangladesh, where the influx slowed down because of the ongoing economic crisis.
Q1FY26 Results announced on Tuesday showed a year -on -year increase in consolidated net profit of 42% £433 crore, of £305 crore a year earlier. Revenue from operations climbed to 15% to £5 842 crore, while income before interest, tax, depreciation and amortization (EBITDA) increased by 26% on £852 crore.
The main division of the medical service has brought a 11% increase in income £2,935 Crore, supported by top operations and growth in special areas such as cardiac, oncology, neurology, gastroenterology and orthopedics. However, 1.5% of the income intervention came from reduced medical tourism from Bangladesh, which decreases from Q3FY25.
Also read | Apollo Hospital: Simplify the corporate structure could lead to renewal
Health player is now trying to attract more patients from other markets. “We do a lot to see how we can participate in some of these markets more actively,” said Madha Sasidhar, president and CEO of hospital division, Mind.
Apollo looks at a larger piece in the African Middle Eastern cluster, where they have already significantly increased income, Sasidhar said. The chain in the hospital also looks at the markets in the Eastern corridor, such as Myanmar and Cambodia, Southeast Asia, as well as the Earth CIS.
“Over the next few months, you will begin to see how some of it will take place,” Sasidhar added.
The chain in the hospital is also looking at six new hospitals and this year a total of more than 1,500 new beds. “There is a significant capacity that will be expanded next year,” said Krishhnan Akhileswarean.
Also read | Apollo for a list of pharmacies and digital health for 18-21 months
The group repeated the plans to add more than 4,300 beds in the next five years and announced the network occupancy to 65% compared to 68% earlier.
Online business
Digital Pharmacy Business Apollo 24/7 is on the way to interruption and Q4FY26, Akhileswaren said.
During the first quarter of FY26, Ahel Demerger announced its Omnicannel Pharmacy and Digital Health Business to the new entity, Apollo Healthtech, which will be shown in the next 12-18 months.
“It’s a good time because if you look at it, at the time we will degene, Q4Fy27 … Until then we should do reasonably good margins. And with this growth we hope it would be according to Q4FY27, it will be a £25,000 Crore Run, which is a considerable number for someone like us to state this company, ”he said.
Also read | Manipal Purchase PURE’S SYHYADRI HOSPITAL from Ontario teachers for 760 MN
Total Digital Health and Distribution of Pharmacy Omnicannel lists 19% of income growth £2 472 crore. Ebitda stood £94 crore against £23 crore in Q1FY25, with margins 3.8%. Net profit cost £57 crore during fiscal.
Apollo hospital shares ended by 0.1% lower on £7 253 on the National Stock Exchange before the results.
(Tagstotranslate) Apollo Hospitals Enterprise Ltd (T) Health Care (T) Medical Tourism (T) Reduced medical tourism from Bangladesh
